HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides
Peptides which can induce specific CTLs for HIV, DNAs encoding for the peptides and medicaments for preventing and/or treating HIV comprising the peptides are provided. According to the present invention, peptides carrying novel CTL epitopes derived from HIV Pol or Env proteins are provided. These peptides can bind to HLA-A11, particularly HLA-A*1101 which is frequently encountered in Japanese people and induce HIV-specific cytotoxic T cells.
1. An isolated DNA molecule coding for a peptide having an amino acid sequence.
2. The DNA molecule of claim 1 , wherein the codon usage of the DNA molecule is optimized for the cell used for expression of said DNA molecule.
3. A host cell comprising the DNA molecule of claim 2 .
4. A host cell comprising the DNA molecule of claim 1 .
5. An expression vector comprising the DNA molecule of claim 1 .
6. A method of inducing cytotoxic CTL targeting to a HIV infected cell comprising:
expressing the DNA molecule of claim 1 in a host cell to produce a peptide of SEQ ID NO: 4;
obtaining said peptide of SEQ ID NO: 4;
administering said peptide of SEQ ID NO: 4 to a subject in need thereof.
7. The method of claim 6 , wherein said administering comprises a method selected from the group consisting of injection, aerosol, and transdermal application.